{"transactions":[{"id":1291799,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-29T21:30:04.000Z","date":"2024-11-20","kind":"other","planned":false,"acquired":true,"shares":473,"price":14.98,"value":7085.54,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":111565,"source":{"system":"sec-edgar","filing":"0000950170-25-010530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017025010530/ownership.xml","form_type":"5"}},{"id":1397877,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock option (Right to Buy)","published_at":"2024-09-30T21:01:16.000Z","date":"2024-09-26","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vested on March 26, 2021, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":89000,"derivative":{"exercise_price":15.29,"expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-110416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024110416/ownership.xml","form_type":"4"}},{"id":1397876,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-09-30T21:01:16.000Z","date":"2024-09-26","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":51.11,"value":1277750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $51.11 per share. The range of sales prices on the transaction date was $50.28 to $51.54 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."}],"balance_after":111092,"source":{"system":"sec-edgar","filing":"0000950170-24-110416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024110416/ownership.xml","form_type":"4"}},{"id":1397875,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-09-30T21:01:16.000Z","date":"2024-09-26","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":15.29,"value":382250.0,"ownership":{"direct":true},"balance_after":136092,"source":{"system":"sec-edgar","filing":"0000950170-24-110416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024110416/ownership.xml","form_type":"4"}},{"id":1448052,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock option (Right to Buy)","published_at":"2024-07-26T20:24:52.000Z","date":"2024-07-25","kind":"exercise","planned":true,"acquired":false,"shares":19056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.28,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":19056},"source":{"system":"sec-edgar","filing":"0000950170-24-086913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024086913/ownership.xml","form_type":"4"}},{"id":1448051,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-26T20:24:52.000Z","date":"2024-07-25","kind":"sale","planned":true,"acquired":false,"shares":19056,"price":53.88,"value":1026737.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $53.88 per share. The range of sales prices on the transaction date was $53.12 to $54.23 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."}],"balance_after":111092,"source":{"system":"sec-edgar","filing":"0000950170-24-086913","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024086913/ownership.xml","form_type":"4"}},{"id":1448050,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-26T20:24:52.000Z","date":"2024-07-25","kind":"exercise","planned":true,"acquired":true,"shares":19056,"price":9.28,"value":176839.68,"ownership":{"direct":true},"balance_after":130148,"source":{"system":"sec-edgar","filing":"0000950170-24-086913","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024086913/ownership.xml","form_type":"4"}},{"id":1452574,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock option (Right to Buy)","published_at":"2024-07-17T21:14:58.000Z","date":"2024-07-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vested on March 31, 2022, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":66000,"derivative":{"exercise_price":20.02,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-084328","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024084328/ownership.xml","form_type":"4"}},{"id":1452573,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-17T21:14:58.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":55,"value":1375000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":111092,"source":{"system":"sec-edgar","filing":"0000950170-24-084328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024084328/ownership.xml","form_type":"4"}},{"id":1452572,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-17T21:14:58.000Z","date":"2024-07-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":20.02,"value":500500.0,"ownership":{"direct":true},"balance_after":136092,"source":{"system":"sec-edgar","filing":"0000950170-24-084328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024084328/ownership.xml","form_type":"4"}},{"id":1462959,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock option (Right to Buy)","published_at":"2024-07-02T20:32:14.000Z","date":"2024-06-28","kind":"exercise","planned":true,"acquired":false,"shares":32129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":19056,"derivative":{"exercise_price":9.28,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":32129},"source":{"system":"sec-edgar","filing":"0000950170-24-080557","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024080557/ownership.xml","form_type":"4"}},{"id":1462958,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-02T20:32:14.000Z","date":"2024-06-28","kind":"sale","planned":true,"acquired":false,"shares":32129,"price":43.61,"value":1401145.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.61 per share. The range of sales prices on the transaction date was $43.28 to $44.13 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 462 shares acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":111092,"source":{"system":"sec-edgar","filing":"0000950170-24-080557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024080557/ownership.xml","form_type":"4"}},{"id":1462957,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-02T20:32:14.000Z","date":"2024-06-28","kind":"exercise","planned":true,"acquired":true,"shares":32129,"price":9.28,"value":298157.12,"ownership":{"direct":true},"balance_after":143221,"source":{"system":"sec-edgar","filing":"0000950170-24-080557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024080557/ownership.xml","form_type":"4"}},{"id":1565951,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-03-20T22:32:35.000Z","date":"2024-03-19","kind":"sale","planned":true,"acquired":false,"shares":6942,"price":42.91,"value":297881.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $42.91 per share. The range of sales prices on the transaction date was $41.04 to $44.00 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."}],"balance_after":110630,"source":{"system":"sec-edgar","filing":"0001209191-24-005009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919124005009/doc4.xml","form_type":"4"}},{"id":1565950,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-03-20T22:32:35.000Z","date":"2024-03-18","kind":"tax_withholding","planned":true,"acquired":false,"shares":3983,"price":38.14,"value":151911.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022 and March 1, 2023.  The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":117572,"source":{"system":"sec-edgar","filing":"0001209191-24-005009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919124005009/doc4.xml","form_type":"4"}},{"id":1591628,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-07T01:01:44.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":95500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 4, 2024."}],"balance_after":95500,"derivative":{"exercise_price":43.51,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":95500},"source":{"system":"sec-edgar","filing":"0001209191-24-004609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919124004609/doc4.xml","form_type":"4"}},{"id":1591627,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-03-07T01:01:44.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2025."}],"balance_after":121555,"source":{"system":"sec-edgar","filing":"0001209191-24-004609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919124004609/doc4.xml","form_type":"4"}},{"id":1687794,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2024-01-04T21:43:51.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":51185,"derivative":{"exercise_price":9.28,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-24-000812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919124000812/doc4.xml","form_type":"4"}},{"id":1687793,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-04T21:43:51.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":35.47,"value":354700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The common stock was sold by the Reporting Person in open market transactions on the transaction date with a volume weighted average sales price of $35.47 per share. The range of sales prices on the transaction date was $34.41 to $36.07 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."}],"balance_after":96055,"source":{"system":"sec-edgar","filing":"0001209191-24-000812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919124000812/doc4.xml","form_type":"4"}},{"id":1687792,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-04T21:43:51.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":9.28,"value":92800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 454 shares acquired under the Issuer's Employee Stock Purchase."}],"balance_after":106055,"source":{"system":"sec-edgar","filing":"0001209191-24-000812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919124000812/doc4.xml","form_type":"4"}},{"id":1749799,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2023-11-03T23:38:21.000Z","date":"2023-11-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":61185,"derivative":{"exercise_price":9.28,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-054425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123054425/doc4.xml","form_type":"4"}},{"id":1749798,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-03T23:38:21.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":28.75,"value":287500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $28.75 per share. The range of sales prices on the transaction date was $28.14 to $29.07 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."}],"balance_after":95601,"source":{"system":"sec-edgar","filing":"0001209191-23-054425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123054425/doc4.xml","form_type":"4"}},{"id":1749797,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-03T23:38:21.000Z","date":"2023-11-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":9.28,"value":92800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 443 shares acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":105601,"source":{"system":"sec-edgar","filing":"0001209191-23-054425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123054425/doc4.xml","form_type":"4"}},{"id":1847827,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2023-06-21T21:32:14.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":71185,"derivative":{"exercise_price":9.28,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-038852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123038852/doc4.xml","form_type":"4"}},{"id":1847826,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-06-21T21:32:14.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":19.97,"value":399400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $19.97 per share. The range of sales prices on the transaction date was $19.86 to $20.32 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."}],"balance_after":95158,"source":{"system":"sec-edgar","filing":"0001209191-23-038852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123038852/doc4.xml","form_type":"4"}},{"id":1847825,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-06-21T21:32:14.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":9.28,"value":185600.0,"ownership":{"direct":true},"balance_after":115158,"source":{"system":"sec-edgar","filing":"0001209191-23-038852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123038852/doc4.xml","form_type":"4"}},{"id":1847824,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-06-21T21:32:14.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":10922,"price":19.96,"value":218003.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $19.96 per share. The range of sales prices on the transaction date was $19.86 to $20.32 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request."}],"balance_after":95158,"source":{"system":"sec-edgar","filing":"0001209191-23-038852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123038852/doc4.xml","form_type":"4"}},{"id":1947000,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-03-17T21:11:10.000Z","date":"2023-03-16","kind":"tax_withholding","acquired":false,"shares":1666,"price":17.12,"value":28521.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022.  The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":106080,"source":{"system":"sec-edgar","filing":"0001209191-23-019774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123019774/doc4.xml","form_type":"4"}},{"id":1973497,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T21:33:30.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":112850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 1, 2023."}],"balance_after":112850,"derivative":{"exercise_price":19.64,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":112850},"source":{"system":"sec-edgar","filing":"0001209191-23-015545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123015545/doc4.xml","form_type":"4"}},{"id":1973496,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-03-03T21:33:30.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":24200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2024."}],"balance_after":107746,"source":{"system":"sec-edgar","filing":"0001209191-23-015545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123015545/doc4.xml","form_type":"4"}},{"id":2043710,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-01-27T21:29:02.000Z","date":"2022-11-20","kind":"other","acquired":true,"shares":482,"price":11.02,"value":5311.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":83546,"source":{"system":"sec-edgar","filing":"0001209191-23-005258","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123005258/doc5.xml","form_type":"5"}},{"id":2043709,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-01-27T21:29:02.000Z","date":"2022-05-20","kind":"other","acquired":true,"shares":1446,"price":11.02,"value":15934.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":83064,"source":{"system":"sec-edgar","filing":"0001209191-23-005258","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123005258/doc5.xml","form_type":"5"}},{"id":2360747,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-03T02:00:41.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 28, 2022."}],"balance_after":91000,"derivative":{"exercise_price":20.02,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001209191-22-015132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122015132/doc4.xml","form_type":"4"}},{"id":2360746,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-03T02:00:41.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2023.."}],"balance_after":81618,"source":{"system":"sec-edgar","filing":"0001209191-22-015132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122015132/doc4.xml","form_type":"4"}},{"id":2411683,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-02-04T21:30:17.000Z","date":"2021-11-19","kind":"other","acquired":true,"shares":837,"price":11.02,"value":9223.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c)."}],"balance_after":62118,"source":{"system":"sec-edgar","filing":"0001209191-22-007202","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122007202/doc5.xml","form_type":"5"}},{"id":2411682,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-02-04T21:30:17.000Z","date":"2021-05-20","kind":"other","acquired":true,"shares":1090,"price":11.02,"value":12011.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c)."}],"balance_after":61281,"source":{"system":"sec-edgar","filing":"0001209191-22-007202","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122007202/doc5.xml","form_type":"5"}},{"id":2820208,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T22:23:12.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":114000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 26, 2021."}],"balance_after":114000,"derivative":{"exercise_price":15.29,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":114000},"source":{"system":"sec-edgar","filing":"0001209191-21-016263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919121016263/doc4.xml","form_type":"4"}},{"id":2876645,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2021-02-05T21:43:53.000Z","date":"2020-11-20","kind":"other","acquired":true,"shares":702,"price":11.61,"value":8150.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":60191,"source":{"system":"sec-edgar","filing":"0001209191-21-008100","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919121008100/doc5.xml","form_type":"5"}},{"id":2876644,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2021-02-05T21:43:53.000Z","date":"2020-05-20","kind":"other","acquired":true,"shares":697,"price":14.45,"value":10071.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":59489,"source":{"system":"sec-edgar","filing":"0001209191-21-008100","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919121008100/doc5.xml","form_type":"5"}},{"id":3246420,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-26T21:15:56.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 24, 2020."}],"balance_after":70000,"derivative":{"exercise_price":22.61,"expiration_date":"2030-02-23","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-20-012987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919120012987/doc4.xml","form_type":"4"}},{"id":3279683,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2020-02-11T21:04:45.000Z","date":"2019-05-20","kind":"other","acquired":true,"shares":1471,"price":14.45,"value":21255.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 29,090 shares of restricted stock which remain subject to continued vesting."}],"balance_after":58792,"source":{"system":"sec-edgar","filing":"0001209191-20-008269","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919120008269/doc5.xml","form_type":"5"}},{"id":3599369,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-12T22:43:45.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date of March 8, 2019."}],"balance_after":56250,"derivative":{"exercise_price":25.19,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001209191-19-018983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919119018983/doc4.xml","form_type":"4"}},{"id":3663120,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-12T22:29:09.000Z","date":"2018-11-20","kind":"other","acquired":true,"shares":1470,"price":14.45,"value":21241.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 55,851 shares of restricted stock issued upon the Reporting Person's early exercise of a stock option that remain unvested. 25% of the restricted shares vested on January 4, 2019, and 1/48th of the total remaining number of restricted shares will vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":57321,"source":{"system":"sec-edgar","filing":"0000899243-19-003326","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000089924319003326/doc5.xml","form_type":"5"}},{"id":4205357,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-09-19T16:44:14.000Z","date":"2017-09-18","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A portion of the shares vest upon the achievement of various clinical and corporate milestones."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"A portion of the shares vest upon the achievement of various clinical and corporate milestones."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-053301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000120919117053301/doc4.xml","form_type":"4"}},{"id":4205356,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-09-19T16:44:14.000Z","date":"2017-09-18","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1/3rd of the total number of shares subject to the restricted stock unit shall vest on each December 31 of 2018, 2019 and 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,414, 1,603, 350, and 1,989 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2015, May 20, 2016, November 18, 2016 and May 19, 2017, respectively."}],"balance_after":10356,"source":{"system":"sec-edgar","filing":"0001209191-17-053301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000120919117053301/doc4.xml","form_type":"4"}},{"id":4359766,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-04-04T16:40:09.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2017."}],"balance_after":25000,"derivative":{"exercise_price":7.8,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-024853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000120919117024853/doc4.xml","form_type":"4"}},{"id":4359765,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":83801,"kind":"person","name":"Wilson Marc","position":1,"cik":"0001702265","reported_name":"Wilson Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-04-04T16:40:09.000Z","date":"2016-03-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 16, 2016."}],"balance_after":12000,"derivative":{"exercise_price":9.89,"expiration_date":"2026-03-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-17-024853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000120919117024853/doc4.xml","form_type":"4"}}]}